Bill118th CongressFiled Dec 14, 2023Health
S.Res. 510
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedDec 14, 2023
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Who’s behind it
Sen. Warren, Elizabeth [D-MA](D-MA)Sponsor
41 cosponsors38 D3 I
41cosponsors1committees2actions
- Introduced in SenateDec 14, 2023
- Dec 14, 2023IntroReferral
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)
Health, Education, Labor, and Pensions Committee - Dec 14, 2023IntroReferral10000
Introduced in Senate